| P/E (FY) | — | Sales (TTM) | CNY 460.5M |
| Earnings (TTM) | -CNY 92.8M | ROE | — |
| Net Margin | −20.15% | ROIC | −4.22% |
| Debt / Equity | — | TD / EBITDA | — |
| EPS Growth 3Y | — | Sales Growth 3Y | −1.28% |
| Market Cap | — | Trading Days | 4177 |
| 52W High | 6.98 |
| 52W Low | 3.18 |
| % Off High | −34.10% |
| YTD | 19.17% | 1Y | −15.75% |
| 3Y | −69.13% | 5Y | −83.86% |
| 10Y | −89.35% | Since incept. (ann.) | −13.37% |
| Ann. Volatility (1Y) | 86.94% | Ann. Volatility (3Y) | 163.47% |
| Sharpe (1Y) | 0.22 | Sharpe (3Y) | 0.39 |
| Max Drawdown (1Y) | −50.29% | Max Drawdown (3Y) | −83.67% |
| Beta (3Y, vs SPY) | −1.20 |
| Ticker | Name | Mkt cap | P/E |
|---|---|---|---|
| HIMS | Hims & Hers Health, Inc. | $7.57B | 57.5 |
| TDOC | Teladoc Health, Inc. | $1.69B | — |
| TOI | Oncology Institute, Inc. | $494.9M | — |
| SBC | SBC Medical Group Holdings Inc | $330.1M | 6.4 |
| AIRS | Airsculpt Technologies, Inc. | $328.7M | — |
| LFMD | LifeMD, Inc. | $185.7M | 15.4 |
| HLYK | HealthLynked Corp | $9.0M | — |
| LLY | ELI LILLY & Co | $1.15T | 53.2 |
| JNJ | JOHNSON & JOHNSON | $642.79B | 24.2 |
| ONC | BeOne Medicines Ltd. | $477.60B | 1739.3 |
| ABBV | AbbVie Inc. | $465.02B | 111.5 |
| MRK | Merck & Co., Inc. | $325.57B |
| 18.1 |
